Davinder Parsad

Chandigarh, CH, India

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 224 publications

Revisiting Stability: The Missing Therapeutic Endpoint in Active Vitiligo Trials.

Revisiting Stability: The Missing Therapeutic Endpoint in Active Vitiligo Trials.

Journal: Pigment cell & melanoma research
Published: May 04, 2026

Definition of Severity and Relapse for Vitiligo: An International Consensus Statement.

Definition of Severity and Relapse for Vitiligo: An International Consensus Statement.

Journal: JAMA dermatology
Published: March 25, 2026

Site-Specific Immunological Changes Induced by Narrowband UVB in Acral and Non-Acral Vitiligo.

Site-Specific Immunological Changes Induced by Narrowband UVB in Acral and Non-Acral Vitiligo.

Journal: Experimental dermatology
Published: March 13, 2026

Erythematous Centrally Umbilicated Nodular Lesion in a Young Girl.

Erythematous Centrally Umbilicated Nodular Lesion in a Young Girl.

Journal: Indian dermatology online journal
Published: December 30, 2025

Description of the Tranquillo Phase 3 Clinical Trial Designs/Study Protocols to Assess Ritlecitinib in Adults and Adolescents with Nonsegmental Vitiligo.

Description of the Tranquillo Phase 3 Clinical Trial Designs/Study Protocols to Assess Ritlecitinib in Adults and Adolescents with Nonsegmental Vitiligo.

Journal: Dermatology and therapy
Published: December 15, 2025

Vitiligo.

Vitiligo.

Journal: Nature reviews. Disease primers
Published: November 05, 2025

Assessment of vitiligo in clinical practice: a cross-sectional survey among experts.

Assessment of vitiligo in clinical practice: a cross-sectional survey among experts.

Journal: The Journal of dermatological treatment
Published: October 10, 2025

Social determinants of health, quality of life, and productivity outcomes among adults with vitiligo in Brazil, China, India, and South Africa.

Social determinants of health, quality of life, and productivity outcomes among adults with vitiligo in Brazil, China, India, and South Africa.

Journal: The Journal of dermatological treatment
Published: September 08, 2025

6-Bromo-Indirubin-3'-Oxime (6BIO) mitigates oxidative stress and immune dysregulation to promote melanocyte regeneration in vitiligo.

6-Bromo-Indirubin-3'-Oxime (6BIO) mitigates oxidative stress and immune dysregulation to promote melanocyte regeneration in vitiligo.

Journal: Free radical biology & medicine
Published: July 25, 2025

Treatment of Acquired Dermal Macular Hyperpigmentation With Oral Isotretinoin: A Multi-Institutional Retrospective Study of 121 Cases.

Treatment of Acquired Dermal Macular Hyperpigmentation With Oral Isotretinoin: A Multi-Institutional Retrospective Study of 121 Cases.

Journal: Pigment cell & melanoma research
Published: June 13, 2025

Depression and depressive symptoms among people living with vitiligo: findings from the cross-sectional, population-based global VALIANT survey.

Depression and depressive symptoms among people living with vitiligo: findings from the cross-sectional, population-based global VALIANT survey.

Journal: The Journal of dermatological treatment
Published: June 04, 2025

Comment on "Patch Testing to Identify Allergens Causing Pigmented Contact Dermatitis: A Retrospective Study".

Comment on "Patch Testing to Identify Allergens Causing Pigmented Contact Dermatitis: A Retrospective Study".

Journal: Indian dermatology online journal
Published: May 17, 2025
Showing 1-12 of 224

Last Updated: 09/26/2026